Loading clinical trials...
Loading clinical trials...
A Multicentre, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis
Conditions
Interventions
Placebo
Nerinetide
Locations
81
United States
St. Joseph's Hospital & Medical Center
Phoenix, Arizona, United States
Providence Little Company of Mary Medical Center - Torrance
Torrance, California, United States
Swedish Medical Center
Englewood, Colorado, United States
Baptist Health Research Institute
Jacksonville, Florida, United States
University of Miami, Jackson Memorial Hospital
Miami, Florida, United States
Grady Memorial Hospital
Atlanta, Georgia, United States
Start Date
December 6, 2020
Primary Completion Date
August 31, 2023
Completion Date
August 31, 2023
Last Updated
June 22, 2025
NCT06658197
NCT02879123
NCT05338697
NCT06075628
NCT06094478
NCT06157502
Lead Sponsor
NoNO Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions